Values represent mean ± SEM of each experimental group (normal weight n = 60; overweight n = 54; obesity n = 34). Asterisks above bars (*p < 0.05; **p < 0.01; ***p < 0.001) indicate significant differences by Mann-Whitney U post-hoc test. C means control subjects and BC means breast cancer patients. 2 ) 25.6 ± 0.6 29.5 ± 1.1* 25.5 ± 0.6 29.1 ± 0.8 * Systolic pressure (mm Hg) 109.3 ± 1.9 128.5 ± 5.1** 118 ± 3.9 136.9 ± 3.6*** Diastolic pressure (mm Hg) 69.1 ± 1.6 77.7 ± 4.6 70.5 ± 2.4 81.1 ± 2.8* Waist perimeter (cm) 84.1 ± 1.5 96.1 ± 2.6** 85.1 ± 2.1 94.2 ± 2.1** Number of children 1.9 ± 0.1 2.1 ± 0.2 2.1 ± 0.1 2.6 ± 0. Values represent mean ± SEM of each parameter in the different groups (premenopause n = 86; postmenopause n = 45). P-value indicate global differences by 2-way ANOVA or Kruskal Wallis tests (p < 0.05 was considered significant). 0,099 Differences in glucose levels during OGTT were analyzed with or without correction by age using linear regression analysis. A first group of controls (n = 71) and breast cancer patients (n = 77) and a second group of premenopausal controls (n = 48) and premenopausal breast cancer cases (n = 38) were analyzed. F-statistic indicates the variability of the means in each group and p-value indicates statistical significance when is < 0.05.
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